Rapport Therapeutics (RAPP) Treasury Shares (2023 - 2026)

Rapport Therapeutics (RAPP) has 4 years of Treasury Shares data on file, last reported at $295413.0 in Q1 2026.

• On a quarterly basis, Treasury Shares rose 2012.05% year-over-year to $295413.0 in Q1 2026; TTM through Mar 2026 was $295413.0, a 2012.05% increase from a year earlier, with the FY2025 full-year figure at $411833.0, down 57.83% from the prior year.
• Treasury Shares for Q1 2026 stood at $295413.0, down from $411833.0 in the prior quarter.
• Over the last five years, Treasury Shares for RAPP reached as high as $100.2 million in Q2 2023 and fell as low as $13987.0 in Q1 2025.
• Historically, Treasury Shares has averaged $33.8 million across 4 years, with a median of $1.0 million in 2024.
• Across the five-year window, Treasury Shares slumped 99.99% in 2025 and jumped 2012.05% in 2026, its largest moves.
• Year by year, Treasury Shares stood at $100.2 million in 2023, then plunged by 99.03% to $976596.0 in 2024, then plunged by 57.83% to $411833.0 in 2025, then retreated by 28.27% to $295413.0 in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $295413.0 in Q1 2026, $411833.0 in Q4 2025, and $544235.0 in Q3 2025.